<![CDATA[Inclaudamab - ACC]]>Igår fik vi så lidt mere smag på Inclacumab.

fra 2.50 cirka.

We have a new target! It appears it really makes a difference. Concern about safety!

Lige på grænsen af p 0.05.

Vi skal have et større forsøg.

http://www.cardiosource.org/News-Media/Cardiosource-Video-News.aspx?vidid=w59UKuQTlkO6LWftXyS-KA

Late-Breaking Clinical Trials III: Chronic CAD/Stable Ischemic Heart Disease and Acute Coronary Syndromes
Session 302
Sunday, March 10, 10:45 a.m. - 12:15 p.m.
South, Esplanade Ballroom

The STREAM Trial
Early Administration of Eplerenone in Patients with Acute Myocardial Infarction Without Heart Failure: Results of the Randomized, Double-Blind, Placebo-Controlled REMINDER Trial
Effects of the P-Selectin Antagonist Inclacumab in the Select-Acute Coronary Syndromes Trial
Randomized Comparison of High-dose Oral Vitamins vs. Placebo in the Trial to Assess Chelation Therapy
Evaluation of Ranolazine in Patients with Type 2 Diabetes Mellitus and Chronic Stable Angina: Results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects with Chronic Stable Angina (TERISA) randomized clinical trial

]]>https://dev.proinvestor.com/forum/topic/437140/inclaudamab-accRSS for NodeMon, 27 Jul 2026 05:55:39 GMTMon, 11 Mar 2013 08:17:36 GMT60<![CDATA[Reply to Inclaudamab - ACC on Mon, 11 Mar 2013 08:20:56 GMT]]>og her link fra Chat

http://www.theheart.org/article/1516411.do

He continued: ''This is still a pilot study with fewer than 600 patients-getting something definitive will take a much larger study. This, however, is the kind of study we should be doing: rationally based and scientific developed. This looks very promising, and I hope we get to see this in larger trials."

]]>https://dev.proinvestor.com/forum/post/9444490https://dev.proinvestor.com/forum/post/9444490Mon, 11 Mar 2013 08:20:56 GMT